To confirm the clinicopathological role of the TIP30 mRNA expression level in NSCLC patients, we performed a meta-analysis using 3 microarray datasets with 11 probes for the relapse-free survival of lung cancer patients. This evidence concerns the gene HTATIP2 and lung cancer.